PRC2 loss of function confers a targetable vulnerability to BET proteins in T-ALL.
Andrieu GP, Kohn M, Simonin M, Smith CL, Cieslak A, Dourthe MÉ, Charbonnier G, Graux C, Huguet F, Lhéritier V, Dombret H, Spicuglia S, Rousselot P, Boissel N, Asnafi V.
Andrieu GP, et al.
Blood. 2021 Nov 11;138(19):1855-1869. doi: 10.1182/blood.2020010081.
Blood. 2021.
PMID: 34125178
Free PMC article.
Clinical Trial.